Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy-Reference-Cited by-同舟云学术

Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy

Published:2013-06-27 Issue:2 Volume:109 Page:312-317
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cheah C Y,Hofman M S,Dickinson M,Wirth A,Westerman D,Harrison S J,Burbury K,Wolf M,Januszewicz H,Herbert K,Prince H M,Carney D A,Ritchie D S,Hicks R J,Seymour J F

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013338.pdf

Reference25 articles.

1. A predictive model for aggressive non-Hodgkin's lymphoma (1993) The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329 (14): 987–994.

2. Abel GA, Vanderplas A, Rodriguez MA, Crosby AL, Czuczman MS, Niland JC, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, LaCasce AS (2012) High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leuk Lymphoma 53 (6): 1113–1116.

3. Armitage JO (2007) How I treat patients with diffuse large B-cell lymphoma. Blood 110 (1): 29–36.

4. Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29 (14): 1844–1854.

5. El-Galaly T, Prakash V, Christiansen I, Madsen J, Johansen P, Boegsted M, Johnsen HE, Bukh A (2011) Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center. Leuk Lymphoma 52 (4): 597–603.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in biology, diagnosis and treatment of DLBCL;Annals of Hematology;2024-07-17

2. Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas;Cancers;2024-05-15

3. Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma;The Oncologist;2024-01-31

4. Measurable Residual Disease Monitoring in Lymphoma;Current Hematologic Malignancy Reports;2023-11-06

5. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1—Clinical);Journal of Nuclear Medicine;2022-07-14